Abstract: The present invention relates to a colorimetric biosensor, preparation method thereof, and antibiotic susceptibility testing method using the same, and more specifically, in the present invention, it is possible to prepare a colorimetric biosensor comprising a porous hydrogel structure including polydiacetylene and a hydrogel polymer (alginate, PEG-DA, etc.); and a microbial nutrient source, and it may be applied to a colorimetric biosensor for detecting microorganisms or a method for testing antibiotic susceptibility of microorganisms for allowing in real-time measurement and exhibiting excellent sensitivity using the colorimetric biosensor.

Abstract: The present invention provides a novel compound represented by Chemical Formula 2, or a pharmaceutically acceptable salt thereof. The novel compound according to the present invention exhibits an excellent acid secretion inhibitory effect.

Abstract: The present invention provides a novel compound represented by Chemical Formula 2, or a pharmaceutically acceptable salt thereof. The novel compound according to the present invention exhibits an excellent acid secretion inhibitory effect.

Abstract: Disclosed are novel compounds of Chemical Formula 1, optical isomers of the compounds, and pharmaceutically acceptable salts of the compounds or the optical isomers. The compounds, isomers, and salts exhibit excellent activity as GLP-1 receptor agonists. In particular, they, as GLP-1 receptor agonists, exhibit excellent glucose tolerance, thus having a great potential to be used as therapeutic agents for metabolic diseases. Moreover, they exhibit excellent pharmacological safety for cardiovascular systems.

Abstract: The present invention provides a novel compound represented by Chemical Formula 2, or a pharmaceutically acceptable salt thereof. The novel compound according to the present invention exhibits an excellent acid secretion inhibitory effect.

Abstract: A refrigerator is proposed. In the refrigerator, a cool air passage for a freezing compartment which guides the flow of cool air to the freezing compartment, and a cool air passage for an ice-making compartment which guides the flow of cool air to the ice-making compartment partially share the cool air with each other. Through the sharing of cool air, the amount of cool air supplied to the freezing compartment is increased and sufficient cool air is supplied to the refrigerating compartment. Accordingly, sufficient cool air is supplied to the refrigerating compartment, the freezing compartment, and the ice-making compartment even with a single evaporator.

Abstract: Disclosed are novel compounds of Chemical Formula 1, optical isomers of the compounds, and pharmaceutically acceptable salts of the compounds or the optical isomers. The compounds, isomers, and salts exhibit excellent activity as GLP-1 receptor agonists. In particular, they, as GLP-1 receptor agonists, exhibit excellent glucose tolerance, thus having a great potential to be used as therapeutic agents for metabolic diseases. Moreover, they exhibit excellent pharmacological safety for cardiovascular systems.

Abstract: Disclosed are novel compounds of Chemical Formula 1, optical isomers of the compounds, and pharmaceutically acceptable salts of the compounds or the optical isomers. The compounds, isomers, and salts exhibit excellent activity as GLP-1 receptor agonists. In particular, they, as GLP-1 receptor agonists, exhibit excellent glucose tolerance, thus having a great potential to be used as therapeutic agents for metabolic diseases. Moreover, they exhibit excellent pharmacological safety for cardiovascular systems.

Abstract: The present invention provides novel compounds of chemical formula 1, optical isomers of the compounds, or a pharmaceutically acceptable salts of the compounds, or the optical isomers. The compounds, isomers, and salts exhibits excellent activity as GLP-1 receptor agonists. Particularly, they, as GLP-1 receptor agonists, exhibit excellent glucose tolerance, thus having a great potential to be used therapeutic agents for metabolic diseases. In addition, they exhibits excellent pharmacological safety for cardiovascular systems.

Abstract: Provided are a method and an apparatus for determining a breathing status of a person using a depth camera. The method of determining a breathing status of a person using a depth camera may include acquiring a depth map by photographing one side of a person using a depth camera, extracting a region of the person by separating a background from the acquired depth map, extracting a breathing region from the extracted region of the person, obtaining a depth value for each point of the extracted breathing region for a preset time, and determining a breathing status including a volume of breathing and the number of the breathings by analyzing the obtained depth value. Therefore, it is possible to accurately determine the breathing status of the person in a non-contact manner.

Abstract: An interactive content control apparatus and method includes a depth information acquisition unit for acquiring an image that includes depth information by capturing a static background object and a dynamic foreground object, and for calculating depth maps based on respective depth values of the static background object and the dynamic foreground object from the image, a display unit for projecting image content including a background image and an object image on a surface of the static background object captured by the depth information acquisition unit, and an image mapping unit for recognizing the dynamic foreground object depending on the depth maps based on the depth values calculated by the depth information acquisition unit, and controlling the display unit so that an object image projected on the surface of the static background object is transferred to and projected on a surface of the dynamic foreground object.

Abstract: An interactive content control apparatus and method includes a depth information acquisition unit for acquiring an image that includes depth information by capturing a static background object and a dynamic foreground object, and for calculating depth maps based on respective depth values of the static background object and the dynamic foreground object from the image, a display unit for projecting image content including a background image and an object image on a surface of the static background object captured by the depth information acquisition unit, and an image mapping unit for recognizing the dynamic foreground object depending on the depth maps based on the depth values calculated by the depth information acquisition unit, and controlling the display unit so that an object image projected on the surface of the static background object is transferred to and projected on a surface of the dynamic foreground object.

Abstract: A motion platform system includes: a wide-viewing-angle display configured to provide images according to user's head movement; a paragliding harness; a control hand brake; a top frame configured to fix the paragliding harness; a lamp structure configured to support the top frame; and a computing device configured to produce contents for the images.

Abstract: An organic light emitting display device is disclosed which includes: a memory in which gamma setting data is stored; a data driver configured to include a gamma voltage generator; a timing controller configured to download the gamma setting data from the memory and apply a select signal to the gamma voltage generator; and a power supplier configured to apply reference voltages to the gamma voltage generator, wherein the select signal is used to vary a gamma curve by enabling the reference voltages to be adjusted in their levels.

Abstract: There are provided a device for displaying virtual reality overlapping the real world and a method thereof. A collimated display device for augmented reality includes a virtual image providing unit configured to modulate an image of the virtual object to light and project the result; and a collimation mirror made of a translucent material that reflects light of the image of the virtual object to a user's field of vision and provides the image of the virtual object overlapping the real world. Therefore, it is possible for the user to see an image of the virtual object that is an additional image matching the real world.

Abstract: An organic light emitting display device is disclosed which includes: a memory in which gamma setting data is stored; a data driver configured to include a gamma voltage generator; a timing controller configured to download the gamma setting data from the memory and apply a select signal to the gamma voltage generator; and a power supplier configured to apply reference voltages to the gamma voltage generator, wherein the select signal is used to vary a gamma curve by enabling the reference voltages to be adjusted in their levels.

Abstract: We disclose synthetic peptide fragments comprising amino acid sequences of specific antigen sites of pathogenic Newcastle disease virus in birds, and more particularly synthetic peptide fragments that comprise polybasic amino acid sequences at the cleavage site of the F protein of pathogenic Newcastle disease virus and that induce humoral immune responses in hosts while reacting only with antibodies to pathogenic Newcastle disease virus and are useful to differentiate infected individuals from vaccinated individuals.

Abstract: A method and system for managing widgets in a portable terminal is disclosed. If a request is made to register a widget in the widget tray having already the preset number of widgets, the lowest priority widget is removed from the widget tray. Information regarding the removed widget is stored in the reserved stack. If at least one widget is removed from the widget tray, the widget stored in the reserved stack is automatically registered in the widget tray. Accordingly, the widget tray can maintain the preset number of widgets in the widget tray.

Abstract: We disclose synthetic peptide fragments comprising amino acid sequences of specific antigen sites of pathogenic Newcastle disease virus in birds, and more particularly synthetic peptide fragments that comprise polybasic amino acid sequences at the cleavage site of the F protein of pathogenic Newcastle disease virus and that induce humoral immune responses in hosts while reacting only with antibodies to pathogenic Newcastle disease virus and are useful to differentiate infected individuals from vaccinated individuals.